未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial Ohman, E. Magnus; Roe, Matthew T.; Steg, P. Gabriel; James, Stefan K.; Povsic, Thomas J.; White, Jennifer; Rockhold, Frank; Plotnikov, Alexei; Mundl, Hardi; Strony, John; Sun, Xiang; Husted, Steen; Tendera, Michal; Montalescot, Gilles; Cecilia Bahit, M.; Ardissino, Diego; Bueno, Hector; Claeys, Marc J.; Nicolau, Jose C.; Cornel, Jan H.; Goto, Shinya; Kiss, Robert Gabor; Guray, Umit; Park, Duk-Woo; Bode, Christoph; Welsh, Robert C.; Gibson, C. Michael 分享 收藏
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome Mega, Jessica L.; Braunwald, Eugene; Wiviott, Stephen D.; Bassand, Jean-Pierre; Bhatt, Deepak L.; Bode, Christoph; Burton, Paul; Cohen, Marc; Cook-Bruns, Nancy; Fox, Keith A. A.; Goto, Shinya; Murphy, Sabina A.; Plotnikov, Alexei N.; Schneider, David; Sun, Xiang; Verheugt, Freek W. A.; Gibson, C. Michael 分享 收藏
Rationale and design of the Anti-Xa Therapy to Lower cardiovascular events in Addition to standard therapy in Subjects with Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 51 (ATLAS-ACS 2 TIMI 51) trial: A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome Gibson, C. Michael; Mega, Jessica L.; Burton, Paul; Goto, Shinya; Verheugt, Freek; Bode, Christoph; Plotnikov, Alexei; Sun, Xiang; Cook-Bruns, Nancy; Braunwald, Eugene 分享 收藏
Pharmacokinetics and pharmacodynamics of rivaroxaban and its effect on biomarkers of hypercoagulability in patients with chronic heart failure Gheorghiade, Mihai; Thyssen, An; Zolynas, Robert; Nadar, Venkatesh K.; Greenberg, Barry H.; Mehra, Mandeep; Sun, Xiang; Tian, Hong; Plotnikov, Alexei N.; Burton, Paul. 分享 收藏
分享 收藏